As DNMT3B is a de novo methyltransferase, we hypothesized that its contribution to the increased malignancy of the tumours might be due to its ability to silence some critical tumour suppressor genes following an ectopic DNA-methylation-dependent silencing of these genes. Here, DNMT3B is linked to neoplasm.